Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

iPower Signs Non-Binding LOI for Proposed $6 Million GPU Deployment

iPower Signs Non-Binding LOI for Proposed $6 Million GPU Deployment

iPower Inc. announced signing a non-binding letter of intent with a prospective customer to lease high-performance GPU systems valued at approximately $6 million, with an anticipated 36-month lease term. The deal marks a significant step in iPower's AI hardware leasing strategy, with potential expansion up to $60 million in total contract value fol…

OKYO Pharma Announces Purchase of Shares by Director

OKYO Pharma Announces Purchase of Shares by Director

OKYO Pharma Limited announced that Non-Executive Director John Brancaccio purchased 5,000 ordinary shares on NASDAQ, raising his total holdings to 35,201 shares. This insider buying comes as the company prepares to initiate a global Phase 3 pivotal clinical trial for urcosimod, targeting neuropathic corneal pain (NCP).

Westamerica Bancorporation Declares Quarterly Cash Dividend

Westamerica Bancorporation Declares Quarterly Cash Dividend

Westamerica Bancorporation announced a quarterly cash dividend of $0.48 per share payable on August 14, 2026, underscoring its reliable earnings and conservative risk profile. The company reported net income of $27.4 million for Q2 2026, or $1.17 diluted earnings per share. Westamerica Bancorporation operates banking and trust offices in Northern a…

UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

UPDATE - Omada Health to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 6, 2026

Omada Health, a Nasdaq-listed virtual healthcare provider focused on chronic condition management, announced it will release its Q2 2026 financial results on August 6, 2026, followed by a conference call to discuss the results. The company highlights its virtual-first care model leveraging human teams, connected devices, and AI to manage conditions…

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

Jyong Biotech Ltd., a Nasdaq-listed Taiwanese biotechnology company, reaffirmed its global licensing partnership strategy to address the expanding Benign Prostatic Hyperplasia (BPH) market. The company is advancing its botanical drug candidate, Botreso®, currently in Phase III clinical trials in the US and Taiwan, aiming to provide safer, long-term…

Silvercrest Asset Management Rebrands International and Global Value Platform as the Silvercrest Focused Value Platform

Silvercrest Asset Management Rebrands International and Global Value Platform as the Silvercrest Focused Value Platform

Silvercrest Asset Management Group Inc. has rebranded its San Diego-based international and global value strategies as the Silvercrest Focused Value Platform, highlighting its disciplined, concentrated, and high-conviction approach to value investing across global markets. The rebranding clarifies the investment philosophy without changing the team…

CBIZ Launches CBIZ Retirement Advantage PEP (Pooled Employer Plan) to Help Middle-Market Businesses Attract, Retain and Reward Talent by Simplifying Retirement Plan Administration and Enhancing Employee Benefits

CBIZ Launches CBIZ Retirement Advantage PEP (Pooled Employer Plan) to Help Middle-Market Businesses Attract, Retain and Reward Talent by Simplifying Retirement Plan Administration and Enhancing Employee Benefits

CBIZ, Inc. has introduced the CBIZ Retirement Advantage Pooled Employer Plan (PEP), aimed at helping middle-market businesses simplify retirement plan administration, lower fiduciary responsibilities, and enhance employee benefits. This new plan provides a professionally managed 401(k) solution with reduced complexity, compliance assurance, and ins…

Greene County Bancorp, Inc. Reports Record Fiscal Year 2026 Earnings, Achieves Highest Quarterly Net Income in Company History, and Earns National Top-Performing Bank Recognition

Greene County Bancorp, Inc. Reports Record Fiscal Year 2026 Earnings, Achieves Highest Quarterly Net Income in Company History, and Earns National Top-Performing Bank Recognition

Greene County Bancorp, Inc. reported record net income of $41.0 million for fiscal year 2026, marking a 31.7% increase over the previous year. The company achieved all-time highs in assets ($3.2 billion), net loans ($1.7 billion), and deposits ($2.7 billion). It also earned national recognition as one of the top-performing banks under $5 billion in…

InterPrivate Investment Partners V Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on or About July 27, 2026

InterPrivate Investment Partners V Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on or About July 27, 2026

InterPrivate Investment Partners V will allow holders of its IPO units to separately trade Class A ordinary shares and warrants beginning on or about July 27, 2026, on the Nasdaq Global Market under the symbols IPVV and IPVVW, respectively. Unseparated units will continue trading as IPVVU. The company is a blank check/SPAC seeking an initial busine…

Virtuix Expects to Report Major Sales Growth Following Meta Launch; Announces First Quarter FY2027 Results Conference Call

Virtuix Expects to Report Major Sales Growth Following Meta Launch; Announces First Quarter FY2027 Results Conference Call

Virtuix Holdings Inc. announced its upcoming Q1 FY2027 earnings call, highlighting expected major sales growth driven by the launch of Omni One for Meta's Quest platform. The company is also expanding its presence in defense AI simulations, NASA deployments, and healthcare collaborations, signaling strong operational momentum and multiple growth in…

Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors

Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors

Longeveron Inc., a NASDAQ-listed clinical stage biotechnology company focused on cellular therapies, announced the election of Dr. Deborah D. Ascheim to its Board of Directors. Dr. Ascheim brings over 30 years of experience in biotech clinical and executive roles, particularly in gene, cell, and biologic therapies. Her addition is expected to suppo…